The role of melanin-concentrating hormone in energy homeostasis and mood disorders

Journal of Molecular Neuroscience

Volumn 39, Issue 1-2, 2009, Pages 86-98

  Antal Zimanyi, Ildiko ^a   Khawaja, Xavier ^a  

^a PFIZER INC   (United States)

Author keywords

Anxiety; Depression; MCH; MCHR1; Melanin concentrating hormone; Obesity

Indexed keywords

A 665798; A 777903; ATC 0065; ATC 0175; CITALOPRAM; DABA 821; DABA 822; GW 3430; GW 803430; MELANIN; MELANIN CONCENTRATING HORMONE; MELANIN CONCENTRATING HORMONE RECEPTOR 1 ANTAGONIST; N (6 DIMETHYLAMINOMETHYL 5,6,7,8 TETRAHYDRO 2 NAPHTHYL) 4' FLUORO 1,1' BIPHENYL 4 CARBOXAMIDE; SB 568849; SNAP 7941; SNAP 94847; UNCLASSIFIED DRUG;

ANXIETY; ANXIETY DISORDER; DEPRESSION; ENERGY BALANCE; ENERGY EXPENDITURE; HYPOTHALAMUS; MOOD DISORDER; NONHUMAN; OBESITY; REVIEW;

AFFECT; ANIMALS; ANIMALS, GENETICALLY MODIFIED; EATING; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; HYPOTHALAMIC HORMONES; MELANINS; MOOD DISORDERS; OBESITY; PITUITARY HORMONES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PITUITARY HORMONE; RECEPTORS, SOMATOSTATIN;

EID: 74149094598     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-009-9207-6     Document Type: Review

References (100)

1. Adamantidis, A., Thomas, E., Foidart, A., Tyhon, A., Coumans, B., Minet, A., et al. (2005). Disrupting the melanin-concentrating hormone receptor 1 in mice leads to cognitive deficits and alterations of NMDA receptor function. The European Journal of Neuroscience, 21, 2837-2844. doi:10.1111/j.1460- 9568.2005. 04100.x.
2. Ahnaou, A., Drinkenburg, W. H. I. M., Bouwknecht, J. A., Alcazar, J., Steckler, T., & Dautzenberg, F. M. (2008). Blocking melaninconcentrating hormone MCH1 receptor affects rat sleep-wake architecture. European Journal of Pharmacology, 579, 177-188. doi:10.1016/j.ejphar.2007.10.017.
3. Alon, T., & Friedman, J. M. (2006). Late-onset leanness in mice with targeted ablation of melanin concentrating hormone neurons. The Journal of Neuroscience, 26, 389-397. doi:10.1523/JNEUROSCI. 1203-05.2006.
4. An, S., Cutler, G., Zhao, J. J., Huang, S.-G., Tian, H., Li, W., et al. (2001). Identification and characterization of a melaninconcentrating hormone receptor. Proceedings of the National Academy of Sciences of the United States of America, 98, 7576-7581. doi:10.1073/pnas.131200698.
5. Anand, B. K., & Brobeck, J. R. (1951). Localisation of a 'feeding center' in the hypothalamus of the rat. Proceedings of the Society for Experimental Biology and Medicine, 77, 323-324.
6. Antal Zimányi, I., & Poindexter, G. S. (2000). NPY-ergic agents for the treatment of obesity. Drug Development Research, 51, 94-111. doi:10.1002/1098-2299 (200010) 51:2<94::AID-DDR5>3.0.CO;2-Z.
7. Arriaga, F., Dugovic, C., & Wauquier, A. (1988). Effects of lithium on dopamine behavioural supersensitivity induced by rapid eye movement sleep deprivation. Neuropsychobiology, 20, 23-27. doi:10.1159/000118468.
8. Astrand, A., Bohlooly-Y, M., Larsdotter, S., Mahlapuu, M., Andersen, H., Tornell, J., et al. (2004). Mice lacking melanin-concentrating hormone receptor 1 demonstrate increased heart rate associated with altered autonomic activity. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 287, R749-R758. doi:10.1152/ajpregu.00134.2004.
9. Basso, A. M., Bratcher, N. A., Gallagher, K. B., Cowart, M. D., Zhao, C., Sun, M., et al. (2006). Lack of efficacy of melaninconcentrating hormone-1 receptor antagonists in models of depression and anxiety. European Journal of Pharmacology, 540, 115-120. doi:10.1016/j.ejphar.2006.04.043.
10. Bauer, M., Whybrow, P. C., Angst, J., Versiani, M., & Mãller, H.-J. (2002a). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: Acute and continuation treatment of major depressive disorder. The World Journal of Biological Psychiatry, 3, 5-43. doi:10.3109/15622970209150599.
11. Bauer, M., Whybrow, P. C., Angst, J., Versiani, M., & Mãller, H.-J. (2002b). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. The World Journal of Biological Psychiatry, 3, 69-86. doi:10.3109/15622970209150605.
12. Bednarek, M. A., Hreniuk, D. L., Tan, C., Palyha, O. C., MacNeil, D. J., Van der Ploeg, L. H., et al. (2002). Synthesis and biological evaluation in vitro of selective, high affinity peptide antagonists of human melanin-concentrating hormone action at human melaninconcentrating hormone receptor 1. Biochemistry, 41, 6383-6390. doi:10.1021/bi0200514.
13. Bittencourt, J. C., Presse, F., Arias, C., Peto, C., Vaughan, J., Nahon, J. L., et al. (1992). The melanin-concentrating hormone system of the rat brain: An immuno-and hybridization histochemical characterization. The Journal of Comparative Neurology, 319, 218-245. doi:10.1002/cne.903190204.
14. Bluet-Pajot, M. T., Presse, F., Voko, Z., Hoeger, C., Mounier, F., Epelbaum, J., et al. (1995). Neuropeptide-E-I antagonizes the action of melanin-concentrating hormone on stress-induced release of adrenocorticotropin in the rat. Journal of Neuroendocrinology, 7, 297-303. doi:10.1111/j.1365-2826.1995.tb00761.x.
15. Bohlooly, Y. M., Mahlapuu, M., Andersen, H., Astrand, A., Hjorth, S., Svensson, L., et al. (2004). Osteoporosis in MCHR1-deficient mice. Biochemical and Biophysical Research Communications, 318, 964-969. doi:10.1016/j.bbrc.2004.04.122.
16. Borowsky, B., Durkin, M. M., Ogozalek, K., Marzabadi, M. R., DeLeon, J., Heurich, R., et al. (2002). Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nature Medicine, 8, 825-830.
17. Bradley, R. L., Mansfield, J. P., Maratos-Flier, E., & Cheatham, B. (2002). Melanin-concentrating hormone activates signaling pathways in 3 T3-L1 adipocytes. American Journal of Physiology. Endocrinology and Metabolism, 283, E584-E592.
18. Carlini, V. P., Schioth, H. B., & de Barioglio, S. R. (2006). Melaninconcentrating hormone (MCH) reverts the behavioral effects induced by inescapable stress. Peptides, 27, 2300-2306. doi:10. 1016/j.peptides. 2006.03.009.
19. Carr, K. D. (2002). Augmentation of drug reward by chronic food restriction: Behavioral evidence and underlying mechanisms. Physiology & Behavior, 76, 353-364. doi:10.1016/S0031-9384 (02) 00759-X.
20. Castaneda, A. E., Tuulio-Henriksson, A., Marttunen, M., Suvisaari, J., & Lönnqvist, J. (2008). A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. Journal of Affective Disorders, 106, 1-27. doi:10.1016/j.jad.2007. 06.006.
21. Chaki, S., Funakoshi, T., Hirota-Okuno, S., Nishiguchi, M., Shimazaki, T., Iijima, M., et al. (2005). Anxiolytic-and antidepressant-like profile of ATC0065 and ATC0175: Nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists. The Journal of Pharmacology and Experimental Therapeutics, 313, 831-839. doi:10.1124/jpet.104.081711.
22. Chefer, V. I., Czyzyk, T., Bolan, E. A., Moron, J., Pintar, J. E., & Shippenberg, T. S. (2005). Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. The Journal of Neuroscience, 25, 5029-5037. doi:10.1523/JNEUROSCI.0854-05.2005.
23. Chen, Y., Hu, C., Hsu, C. K., Zhang, Q., Bi, C., Asnicar, M., et al. (2002). Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to dietinduced obesity. Endocrinology, 143, 2469-2477. doi:10.1210/en. 143.7.2469.
24. Cryan, J. F., Valentino, R. J., & Lucki, I. (2005). Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neuroscience and Biobehavioral Reviews, 29, 547-569. doi:10.1016/j.neubiorev. 2005.03.008.
25. D'Aquila, P. S., Collu, M., Gessa, G. L., & Serra, G. (1997). Role of D1 and alpha1 receptors in the enhanced locomotor response to dopamine D2-like receptor stimulation induced by repeated electroconvulsive shock. Journal of Psychopharmacology (Oxford, England), 11, 41-44. doi:10.1177/ 026988119701100112.
26. David, D. J., Klemenhagen, K. C., Holick, K. A., Saxe, M. D., Mendez, I., Santarelli, L., et al. (2007). Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3, 4-difluorophenoxy) phenyl]methyl} (4-piperidyl))-4-methylphenyl]-2- methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. The Journal of Pharmacology and Experimental Therapeutics, 321, 237-248. doi:10.1124/jpet.106.109678.
27. DiLeone, R. J., Georgescu, D., & Nestler, E. J. (2003). Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sciences, 73, 759-768. doi:10.1016/S0024-3205 (03) 00408-9.
28. Duman, R. S., Malberg, J., & Thome, J. (1999). Neural plasticity to stress and antidepressant treatment. Biological Psychiatry, 46, 1181-1191. doi:10.1016/S0006-3223 (99) 00177-8.
29. Flier, J. S., & Maratos-Flier, E. (1998). Obesity and the hypothalamus: Novel peptides for new pathways. Cell, 92, 437-440. doi:10. 1016/S0092-8674 (00) 80937-X.
30. Gehlert, D. R., Rasmussen, K., Shaw, J., Xia, L., Craft, L., Coskun, T., et al. (2009). Preclinical evaluation of melanin-concentrating hormone receptor 1 (MCHR1) antagonism for the treatment of obesity and depression. Journal of Pharmacology and Experimental Therapeutics, 329, 429-438.
31. Georgescu, D., Sears, R. M., Hommel, J. D., Barrot, M., Bolanos, C. A., Marsh, D. J., et al. (2005). The hypothalamic neuropeptide melaninconcentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. The Journal of Neuroscience, 25, 2933-2940. doi:10.1523/JNEUROSCI.1714-04.2005.
32. Gibson, W. T., Pissios, P., Trombly, D. J., Luan, J., Keogh, J., Wareham, N. J., et al. (2004). Melanin-concentrating hormone receptor mutations and human obesity: Functional analysis. Obesity Research, 12, 743-749. doi:10.1038/oby.2004.89.
33. Gomori, A., Ishihara, A., Ito, M., Mashiko, S., Matsushita, H., Yumoto, M., et al. (2003). Chronic intracerebroventricular infusion of MCH causes obesity in mice. American Journal of Physiology. Endocrinology and Metabolism, 284, E583-E588.
34. Gonzalez, M. I., Vaziri, S., & Wilson, C. A. (1996). Behavioral effects of [alpha]-MSH and MCH after central administration in the female rat. Peptides, 17, 171-177. doi:10.1016/0196-9781 (95) 02092-6.
35. Handlon, A. L., & Zhou, H. (2006). Melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity. Journal of Medicinal Chemistry, 49, 4017-4022. doi:10.1021/jm058239j.
36. Hanriot, L., Camargo, N., Courau, A. C., Leger, L., Luppi, P. H., & Peyron, C. (2007). Characterization of the melanin-concentrating hormone neurons activated during paradoxical sleep hypersomnia in rats. The Journal of Comparative Neurology, 505, 147-157. doi:10. 1002/cne.21482.
37. Hawes, B. E., Kil, E., Green, B., O'Neill, K., Fried, S., & Graziano, M. P. (2000). The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signaling pathways. Endocrinology, 141, 4524-4532. doi:10.1210/en. 141.12.4524.
38. Hervieu, G. J., Cluderay, J. E., Harrison, D., Meakin, J., Maycox, P., Nasir, S., et al. (2000). The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat. The European Journal of Neuroscience, 12, 1194-1216. doi:10.1046/j.1460-9568.2000.00008.x.
39. Hill, J., Duckworth, M., Murdock, P., Rennie, G., Sabido-David, C., Ames, R. S., et al. (2001). Molecular cloning and functional characterization of MCH2, a novel human MCH receptor. The Journal of Biological Chemistry, 276, 20125-20129. doi:10.1074/jbc. M102068200.
40. Hu, E. X., Wos, J. A., Dowty, M. E., Suchanek, P. M., Ji, W., Chambers, J. B., et al. (2008). Small-molecule melaninconcentrating hormone-1 receptor antagonists require brain penetration for inhibition of food intake and reduction in body weight. The Journal of Pharmacology and Experimental Therapeutics, 324, 206-213.
41. Huang, C. Q., Baker, T., Schwarz, D., Fan, J., Heise, C. E., Zhang, M., et al. (2005). 1-(4-Amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino- pyrrolidin-1-yl)-pyridin-3-yl-amine derivatives as melanin-concentrating hormone receptor-1 antagonists. Bioorganic & Medicinal Chemistry Letters, 15, 3701-3706. doi:10.1016/j.bmcl. 2005.05.130.
42. Hutchinson, N. I., & Ryder, S. W. (2007). Obesity pharmacotherapy from a regulatory perspective: Overview and key challenges. Clinical Pharmacology and Therapeutics, 81, 756-760. doi:10.1038/sj.clpt.6100169.
43. Jeon, J. Y., Bradley, R. L., Kokkotou, E. G., Marino, F. E., Wang, X., Pissios, P., et al. (2006). MCH-/-mice are resistant to agingassociated increases in body weight and insulin resistance. Diabetes, 55, 428-434. doi:10.2337/diabetes.55.02.06.db05-0203.
44. Jezova, D., Bartanusz, V., Westergren, I., Johansson, B. B., Rivier, J., Vale, W., et al. (1992). Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: Evidence for a site of action in brain regions protected by the blood-brain barrier. Endocrinology, 130, 1024-1029. doi:10.1210/en. 130.2.1024.
45. Kela, J., Salmi, P., Rimondini-Giorgini, R., Heilig, M., & Wahlestedt, C. (2003). Behavioural analysis of melanin-concentrating hormone in rats: Evidence for orexigenic and anxiolytic properties. Regulatory Peptides, 114, 109-114. doi:10.1016/S0167-0115 (03) 00114-9.
46. Kennedy, A. R., Todd, J. F., Dhillo, W. S., Seal, L. J., Ghatei, M. A., O'Toole, C. P., et al. (2003). Effect of direct injection of melaninconcentrating hormone into the paraventricular nucleus: Further evidence for a stimulatory role in the adrenal axis via SLC-1. Journal of Neuroendocrinology, 15, 268-272. doi:10.1046/j.1365-2826.2003.00997.x.
47. Kim, N., Meyers, K. M., Mendez-Andino, J. L., Warshakoon, N. C., Ji, W., Wos, J. A., et al. (2006). Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity. Bioorganic & Medicinal Chemistry Letters, 16, 5445-5450. doi:10.1016/j.bmcl.2006. 07.053.
48. Kokkotou, E., Jeon, J. Y., Wang, X., Marino, F. E., Carlson, M., Trombly, D. J., et al. (2005). Mice with MCH ablation resist dietinduced obesity through strain-specific mechanisms. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 289, R117-R124. doi:10.1152/ajpregu. 00861.2004.
49. Kolakowski, L. F., Jung, B. P., Nguyen, T., Johnson, M. P., Lynch, K. R., Cheng, R., et al. (1996). Characterization of a human gene related to genes encoding somatostatin receptors. FEBS Letters, 398, 253-258. doi:10.1016/S0014-5793 (96) 01160-X.
50. Lalonde, R., & Qian, S. (2007). Exploratory activity, motor coordination, and spatial learning in Mchr1 knockout mice. Behavioural Brain Research, 178, 293-304. doi:10.1016/j.bbr. 2007.01.006.
51. Li, X., Tizzano, J. P., Griffey, K., Clay, M., Lindstrom, T., & Skolnick, P. (2001). Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology, 40, 1028-1033. doi:10.1016/S0028-3908 (00) 00194-5.
52. Ludwig, D. S., Mountjoy, K. G., Tatro, J. B., Gillette, J. A., Frederich, R. C., Flier, J. S., et al. (1998). Melanin-concentrating hormone: A functional melanocortin antagonist in the hypothalamus. The American Journal of Physiology, 274, E627-E633.
53. Ludwig, D. S., Tritos, N. A., Mastaitis, J. W., Kulkarni, R., Kokkotou, E., Elmquist, J., et al. (2001). Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. The Journal of Clinical Investigation, 107, 379-386. doi:10.1172/JCI10660.
54. Macdonald, D., Murgolo, N., Zhang, R., Durkin, J. P., Yao, X., Strader, C. D., et al. (2000). Molecular characterization of the melanin-concentrating hormone/receptor complex: Identification of critical residues involved in binding and activation. Molecular Pharmacology, 58, 217-225.
55. Mague, S. D., Pliakas, A. M., Todtenkopf, M. S., Tomasiewicz, H. C., Zhang, Y., Stevens, W. C., Jr., et al. (2003). Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. The Journal of Pharmacology and Experimental Therapeutics, 305, 323-330. doi:10.1124/jpet.102.046433.
56. Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. The Journal of Neuroscience, 20, 9104-9110.
57. Marsh, D. J., Weingarth, D. T., Novi, D. E., Chen, H. Y., Trumbauer, M. E., Chen, A. S., et al. (2002). Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proceedings of the National Academy of Sciences of the United States of America, 99, 3240-3245. doi:10.1073/pnas.052706899.
58. McEwen, B. S. (2003). Mood disorders and allostatic load. Biological Psychiatry, 54, 200-207. doi:10.1016/S0006-3223 (03) 00177-X.
59. Millan, M. J., Gobert, A., Panayi, F., Rivet, J. M., Dekeyne, A., Brocco, M., et al. (2008). The melanin-concentrating hormone1 receptor antagonists, SNAP-7941 and GW3430, enhance social recognition and dialysate levels of acetylcholine in the frontal cortex of rats. The International Journal of Neuropsychopharmacology, 11, 1105-1122. doi:10.1017/S1461145708008894.
60. Monzon, M. E., & De Barioglio, S. R. (1999). Response to novelty after i.c.v. injection of melanin-concentrating hormone (MCH) in rats. Physiology & Behavior, 67, 813-817. doi:10.1016/S0031-9384 (99) 00117-1.
61. Monzon, M. E., de Souza, M. M., Izquierdo, L. A., Izquierdo, I., Barros, D. M., & de Barioglio, S. R. (1999). Melanin-concentrating hormone (MCH) modifies memory retention in rats. Peptides, 20, 1517-1519. doi:10.1016/S0196-9781 (99) 00164-3.
62. Mori, M., Harada, M., Terao, Y., Sugo, T., Watanabe, T., Shimomura, Y., et al. (2001). Cloning of a novel G protein-coupled receptor, SLT, a subtype of the melanin-concentrating hormone receptor. Biochemical and Biophysical Research Communications, 283, 1013-1018. doi:10.1006/bbrc.2001.4893.
63. Navarra, P., Tsagarakis, S., Coy, D. H., Rees, L. H., Besser, G. M., & Grossman, A. B. (1990). Rat melanin concentrating hormone does not modify the release of CRH-41 from rat hypothalamus or ACTH from the anterior pituitary in vitro. The Journal of Endocrinology, 127, R1-R4. doi:10.1677/joe.0. 127R001.
64. Nestler, E. J. (2001). Molecular neurobiology of addiction. The American Journal on Addictions, 10, 201-217. doi:10.1080/105504901750532094.
65. Pissios, P., & Maratos-Flier, E. (2003). Melanin-concentrating hormone: From fish skin to skinny mammals. Trends in Endocrinology and Metabolism, 14, 243-248. doi:10.1016/S1043-2760 (03) 00079-1.
66. Pissios, P., Trombly, D. J., Tzameli, I., & Maratos-Flier, E. (2003). Melanin-concentrating hormone receptor 1 activates extracellular signal-regulated kinase and synergizes with G (s)-coupled pathways. Endocrinology, 144, 3514-3523. doi:10.1210/en. 2002-0004.
67. Pissios, P., Bradley, R. L., & Maratos-Flier, E. (2006). Expanding the scales: The multiple roles of MCH in regulating energy balance and other biological functions. Endocrine Reviews, 27, 606-620. doi:10.1210/er.2006-0021.
68. Pissios, P., Ozcan, U., Kokkotou, E., Okada, T., Liew, C. W., Liu, S., et al. (2007). Melanin concentrating hormone is a novel regulator of islet function and growth. Diabetes, 56, 311-319. doi:10.2337/db06-0708.
69. Presse, F., Hervieu, G., Imaki, T., Sawchenko, P. E., Vale, W., & Nahon, J. L. (1992). Rat melanin-concentrating hormone messenger ribonucleic acid expression: Marked changes during development and after stress and glucocorticoid stimuli. Endocrinology, 131, 1241-1250. doi:10.1210/en. 131.3.1241.
70. Qu, D., Ludwig, D. S., Gammeltoft, S., Piper, M., Pelleymounter, M. A., Cullen, M. J., et al. (1996). A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature, 380, 243-247. doi:10.1038/380243a0.
71. Rodriguez, M., Beauverger, P., Naime, I., Rique, H., Ouvry, C., Souchaud, S., et al. (2001). Cloning and molecular characterization of the novel human melanin-concentrating hormone receptor MCH2. Molecular Pharmacology, 60, 632-639.
72. Rossi, M., Choi, S. J., O'Shea, D., Miyoshi, T., Ghatei, M. A., & Bloom, S. R. (1997). Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology, 138, 351-355. doi:10.1210/en. 138. 1.351.
73. Roy, M., David, N. K., Danao, J. V., Baribault, H., Tian, H., & Giorgetti, M. (2006). Genetic inactivation of melaninconcentrating hormone receptor subtype 1 (MCHR1) in mice exerts anxiolytic-like behavioral effects. Neuropsychopharmacology, 31, 112-120.
74. Roy, M., David, N., Cueva, M., & Giorgetti, M. (2007). A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression. Biological Psychiatry, 61, 174-180. doi:10.1016/j.biopsych.2006.03.076.
75. Rutanen, J., Pihlajamaki, J., Vanttinen, M., Salmenniemi, U., Ruotsalainen, E., Kuulasmaa, T., et al. (2007). Single nucleotide polymorphisms of the MCHR1 gene do not affect metabolism in humans. Obesity (Silver Spring, Md.), 15, 2902-2907. doi:10. 1038/oby.2007.345.
76. Sailer, A. W., Sano, H., Zeng, Z., McDonald, T. P., Pan, J., Pong, S.-S., et al. (2001). Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. Proceedings of the National Academy of Sciences of the United States of America, 98, 7564-7569. doi:10.1073/pnas.121170598.
77. Saito, Y., Cheng, M., Leslie, F. M., & Civelli, O. (2001). Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain. The Journal of Comparative Neurology, 435, 26-40. doi:10.1002/cne.1191.
78. Saito, Y., Tetsuka, M., Yue, L., Kawamura, Y., & Maruyama, K. (2003). Functional role of N-linked glycosylation on the rat melanin-concentrating hormone receptor 1. FEBS Letters, 533, 29-34. doi:10.1016/S0014-5793 (02) 03744-4.
79. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301, 805-809. doi:10.1126/science. 1083328.
80. Serra, G., Collu, M., D'Aquila, P. S., & Gessa, G. L. (1992). Role of the mesolimbic dopamine system in the mechanism of action of antidepressants. Pharmacology & Toxicology, 71 (Suppl 1), 72-85. doi:10.1111/j.1600- 0773.1992.tb01631.x.
81. Shearman, L. P., Camacho, R. E., Sloan Stribling, D., Zhou, D., Bednarek, M. A., Hreniuk, D. L., et al. (2003). Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats. European Journal of Pharmacology, 475, 37-47. doi:10.1016/S0014-2999 (03) 02146-0.
82. Shimada, M., Tritos, N. A., Lowell, B. B., Flier, J. S., & Maratos-Flier, E. (1998). Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature, 396, 670-674. doi:10.1038/25341.
83. Shirayama, Y., Ishida, H., Iwata, M., Hazama, G. I., Kawahara, R., & Duman, R. S. (2004). Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. Journal of Neurochemistry, 90, 1258-1268. doi:10.1111/j.1471-4159.2004. 02589.x.
84. Skofitsch, G., Jacobowitz, D. M., & Zamir, N. (1985). Immunohistochemical localization of a melanin concentrating hormone-like peptide in the rat brain. Brain Research Bulletin, 15, 635-649. doi:10.1016/0361-9230 (85) 90213-8.
85. Smith, D. G., Tzavara, E. T., Shaw, J., Luecke, S., Wade, M., Davis, R., et al. (2005). Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. The Journal of Neuroscience, 25, 914-922. doi:10.1523/JNEUROSCI. 4079-04.2005.
86. Smith, D. G., Davis, R. J., Rorick-Kehn, L., Morin, M., Witkin, J. M., McKinzie, D. L., et al. (2006). Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice. Neuropsychopharmacology, 31, 1135-1145. doi:10.1038/sj.npp. 1300881.
87. Smith, D. G., Qi, H., Svenningsson, P., Wade, M., Davis, R. J., Gehlert, D. R., et al. (2008). Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice. Synapse (New York, N. Y.), 62, 128-136. doi:10.1002/syn. 20473.
88. Smith, D. G., Hegde, L. G., Wolinsky, T. D., Miller, S., Papp, M., Ping, X., et al. (2009). The effects of stressful stimuli and hypothalamic-pituitary- adrenal axis activation are reversed by the melanin-concentrating hormone 1 receptor antagonist SNAP 94847 in rodents. Behavioural Brain Research, 197, 284-291. doi:10.1016/j.bbr.2008.08.026.
89. Sotak, B. N., Hnasko, T. S., Robinson, S., Kremer, E. J., & Palmiter, R. D. (2005). Dysregulation of dopamine signaling in the dorsal striatum inhibits feeding. Brain Research, 1061, 88-96. doi:10.1016/j.brainres. 2005.08.053.
90. Spanagel, R., Herz, A., & Shippenberg, T. S. (1992). Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proceedings of the National Academy of Sciences of the United States of America, 89, 2046-2050. doi:10.1073/pnas.89.6.2046.
91. Suzuki, M., Narnaware, Y. K., Baker, B. I., & Levy, A. (1995). Influence of environmental colour and diurnal phase on MCH gene expression in the trout. Journal of Neuroendocrinology, 7, 319-328. doi:10.1111/j.1365-2826.1995.tb00764.x.
92. Svenningsson, P., Tzavara, E. T., Witkin, J. M., Fienberg, A. A., Nomikos, G. G., & Greengard, P. (2002). Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proceedings of the National Academy of Sciences of the United States of America, 99, 3182-3187. doi:10.1073/pnas.052712799.
93. Swanson, L. W., & Petrovich, G. D. (1998). What is the amygdala? Trends in Neurosciences, 21, 323-331. doi:10.1016/S0166-2236 (98) 01265-X.
94. Takekawa, S., Asami, A., Ishihara, Y., Terauchi, J., Kato, K., Shimomura, Y., et al. (2002). T-226296: A novel, orally active and selective melanin-concentrating hormone receptor antagonist. European Journal of Pharmacology, 438, 129-135. doi:10. 1016/S0014-2999 (02) 01314-6.
95. Tritos, N. A., & Maratos-Flier, E. (1999). Two important systems in energy homeostasis: Melanocortins and melanin-concentrating hormone. Neuropeptides, 33, 339-349. doi:10.1054/npep. 1999.0055.
96. Varas, M. M., Perez, M. F., Ramirez, O. A., & de Barioglio, S. R. (2003). Increased susceptibility to LTP generation and changes in NMDA-NR1 and-NR2B subunits mRNA expression in rat hippocampus after MCH administration. Peptides, 24, 1403-1411. doi:10.1016/j.peptides.2003.09.006.
97. Wang, S., Bihan, J., O'Neill, K., Weig, B., Fried, S., Laz, T., et al. (2001). Identification and pharmacological characterization of a novel human melanin-concentrating hormone receptor, MCH-R2. The Journal of Biological Chemistry, 276, 34664-34670. doi:10. 1074/jbc. M102601200.
98. Wermter, A. K., Reichwald, K., Buch, T., Geller, F., Platzer, C., Huse, K., et al. (2005). Mutation analysis of the MCHR1 gene in human obesity. European Journal of Endocrinology, 152, 851-862. doi:10.1530/eje.1.01917.
99. Willner, P., Hale, A. S., & Argyropoulos, S. (2005). Dopaminergic mechanism of antidepressant action in depressed patients. Journal of Affective Disorders, 86, 37-45. doi:10.1016/j.jad.2004.12.010.
100. Zhou, D., Shen, Z., Strack, A. M., Marsh, D. J., & Shearman, L. P. (2005). Enhanced running wheel activity of both Mch1r-and Pmchdeficient mice. Regulatory Peptides, 124, 53-63. doi:10.1016/j. regpep. 2004.06.026.